NCT03317301View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus

PHASE3CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

November 13, 2017

Study Completion Date

January 30, 2018

Conditions
Pruritus
Interventions
DRUG

HL151

2 times a day(Day, Night), 2 weeks of treatment / Day: HL151 (1Tab)+Talion Tab (Placebo)(1Tab), Night: HL151 (Placebo)(1Tab)+Talion Tab (Placebo)(1Tab)

DRUG

Talion Tab

2 times a day(Day, Night), 2 weeks of treatment / Day: HL151 (Placebo)(1Tab)+Talion Tab (1Tab), Night: HL151 (Placebo)(1Tab)+Talion Tab (1Tab)

Trial Locations (1)

471-701

Hanyang Univ. Guri Hospital, Guri-si

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT03317301 - Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus | Biotech Hunter | Biotech Hunter